A network meta-analysis was performed, which indicated that there was nomortality advantage associated with tight glycemic control in critically illpatients and was often tempered by concerns of inducing hypoglycemia [23, 24].Administering empagliflozin effectively restored the diminished Sirt3 levels andcorrected the abnormal glycolytic pathway. Here, SIRT3 is linked to Hypoglycemia.